Anna R Docherty1,2, Alexis C Edwards2, Fuzhong Yang3, Roseann E Peterson2, Chelsea Sawyers2, Daniel E Adkins1,4, Ashlee A Moore2, Bradley T Webb2, Silviu A Bacanu2, Jonathan Flint5,6, Kenneth S Kendler2. 1. Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA. 2. Virginia Institute for Psychiatric & Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. 3. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 4. Department of Sociology, University of Utah, Salt Lake City, UT, USA. 5. Center for Neurobehavioral Genetics, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA. 6. Department of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
Abstract
BACKGROUND: The extent to which earlier age of onset (AO) is a reflection of increased genetic risk for major depression (MD) is still unknown. Previous biometrical research has provided mixed empirical evidence for the genetic overlap of AO with MD. If AO is demonstrated to be relevant to molecular polygenic risk for MD, incorporation of AO as a phenotype could enhance future genetic studies. METHODS: This research estimated the SNP-based heritability of AO in the China, Oxford and VCU Experimental Research on Genetic Epidemiology (CONVERGE) case-control sample (N = 9,854; MD case, n = 4,927). Common single nucleotide polymorphism heritability of MD was also examined across both high and low median-split AO groups, and best linear unbiased predictor (BLUP) scores of polygenic risk, in split-halves, were used to predict AO. Distributions of genetic risk across early and late AO were compared, and presence of self-reported family history (FH) of MD was also examined as a predictor of AO. RESULTS: AO was not significantly heritable and polygenic risk derived from the aggregated effects of common genetic variants did not significantly predict AO in any analysis. AO was modestly but significantly lower in cases with a first-degree genetic FH of MD. CONCLUSIONS: Findings indicate that AO is associated with greater self-reported genetic risk for MD in cases, yet not associated with common variant polygenic risk for MD. Future studies of early MD may benefit more from the examination of important moderating variables such as early life events.
BACKGROUND: The extent to which earlier age of onset (AO) is a reflection of increased genetic risk for major depression (MD) is still unknown. Previous biometrical research has provided mixed empirical evidence for the genetic overlap of AO with MD. If AO is demonstrated to be relevant to molecular polygenic risk for MD, incorporation of AO as a phenotype could enhance future genetic studies. METHODS: This research estimated the SNP-based heritability of AO in the China, Oxford and VCU Experimental Research on Genetic Epidemiology (CONVERGE) case-control sample (N = 9,854; MD case, n = 4,927). Common single nucleotide polymorphism heritability of MD was also examined across both high and low median-split AO groups, and best linear unbiased predictor (BLUP) scores of polygenic risk, in split-halves, were used to predict AO. Distributions of genetic risk across early and late AO were compared, and presence of self-reported family history (FH) of MD was also examined as a predictor of AO. RESULTS: AO was not significantly heritable and polygenic risk derived from the aggregated effects of common genetic variants did not significantly predict AO in any analysis. AO was modestly but significantly lower in cases with a first-degree genetic FH of MD. CONCLUSIONS: Findings indicate that AO is associated with greater self-reported genetic risk for MD in cases, yet not associated with common variant polygenic risk for MD. Future studies of early MD may benefit more from the examination of important moderating variables such as early life events.
Authors: D N Klein; A F Schatzberg; J P McCullough; F Dowling; D Goodman; R H Howland; J C Markowitz; C Smith; M E Thase; A J Rush; L LaVange; W M Harrison; M B Keller Journal: J Affect Disord Date: 1999-10 Impact factor: 4.839
Authors: Peter Holmans; Myrna M Weissman; George S Zubenko; William A Scheftner; Raymond R Crowe; J Raymond Depaulo; James A Knowles; Wendy N Zubenko; Kathleen Murphy-Eberenz; Diana H Marta; Sandra Boutelle; Melvin G McInnis; Philip Adams; Madeline Gladis; Jo Steele; Erin B Miller; James B Potash; Dean F Mackinnon; Douglas F Levinson Journal: Am J Psychiatry Date: 2007-02 Impact factor: 18.112
Authors: H M van Loo; C D Van Borkulo; R E Peterson; E I Fried; S H Aggen; D Borsboom; K S Kendler Journal: J Affect Disord Date: 2017-10-29 Impact factor: 4.839
Authors: Małgorzata Gałecka; Katarzyna Bliźniewska-Kowalska; Agata Orzechowska; Janusz Szemraj; Michael Maes; Michael Berk; Kuan-Pin Su; Piotr Gałecki Journal: J Pers Med Date: 2021-01-23
Authors: Arvid Harder; Thuy-Dung Nguyen; Joëlle A Pasman; Miriam A Mosing; Sara Hägg; Yi Lu Journal: Transl Psychiatry Date: 2022-03-26 Impact factor: 6.222
Authors: Monika E Talarowska; Małgorzata Kowalczyk; Michael Maes; Andre Carvalho; Kuan-Pin Su; Janusz Szemraj; Piotr Gałecki Journal: Arch Med Sci Date: 2019-02-25 Impact factor: 3.318
Authors: Eleonore D van Sprang; Dominique F Maciejewski; Yuri Milaneschi; Bernet M Elzinga; Aartjan T F Beekman; Catharina A Hartman; Albert M van Hemert; Brenda W J H Penninx Journal: Psychol Med Date: 2020-07-06 Impact factor: 7.723